http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7053175-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0664583e2e15bfecd048a65633152f7 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-16 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate | 1998-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f5e3e67279de3e7abe80015bbb14ead http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34b81c6f5a8d6418d25654a39c864c25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6e7c62069dadba15c1e86ed535996ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fc3ac917b91b877d4dd0a7b74a66900 |
| publicationDate | 2006-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-7053175-B1 |
| titleOfInvention | Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses |
| abstract | Synthetic peptides of the monomer type with 13 to 33 amino acids, in linear form or in a form cyclized by means of inter-cysteine disulphide bridges, have the general formula (I):n nΔ-Z-TrpGlyCys-Θ-CysTyrThrSer-Ω (I)n nwherein Δ is a biotinyl radical, a biocytinyl radical, a hydrogen atom, an acetyl (CH 3 CO—) radical, an aliphatic chain which may contain one or two thiol, an aldehyde functional group, or an amine functional group, Z represents peptide sequence -Ξ 1 -Ser-Ξ 2 -, -Ξ 1 -Gln-Ξ 2 -, or -Ξ 1 -Asn-Ξ 2 -, wherein -Ξ 1 represents a peptide sequence of 0 to 9 amino acids and -Ξ 2 represents a peptide sequence of 0 to 5 amino acids, Θ is -Arg Gly Arg Leu Ile-(SEQ ID NO: 15), -Arg Gly Arg Leu Val-(SEQ ID NO: 16), -Arg Gly Lys Leu Ile- (SEQ ID NO: 17), -Arg Gly Lys Leu Val-(SEQ ID NO: 18), -Lys Gly Arg Leu Ile-(SEQ ID NO: 19), or -Lys Gly Arg Leu Val-(SEQ ID NO: 20), Ω, attached to the —CO— group of serine, is a hydroxyl (—OH) radical, an amino (—NH 2 ) radical, an alkoxy radical having 1 to 6 carbon atoms, a peptide sequence of formula Val-Σ-Ψ wherein Σ represents a sequence of formula -(AA 1 )-Trp Asn-(AA 2 )-(AA 3 ) wherein (AA 1 ) represents an amino acid different from lysine, (AA 2 ) represents an amino acid, and (AA 3 ) is serine or a threonine residue, and Ψ, attached to the —CO— residue of the free AA 3 amino acid, is OH, NH 2 , or an alkoxy radical having from 1 to 6 carbon atoms, and a peptide sequence of formula -Val-Ψ wherein Ψ, attached to the —CO— residue of valine, is OH, NH 2 , or an alkoxy radical having from 1 to 6 carbon atoms. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7838001-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006234213-A1 |
| priorityDate | 1997-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 271.